OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Hydroxychloroquine in the COVID-19 pandemic era: in pursuit of a rational use for prophylaxis of SARS-CoV-2 infection
Marco Infante, Camillo Ricordi, Rodolfo Alejandro, et al.
Expert Review of Anti-infective Therapy (2020) Vol. 19, Iss. 1, pp. 5-16
Open Access | Times Cited: 43
Marco Infante, Camillo Ricordi, Rodolfo Alejandro, et al.
Expert Review of Anti-infective Therapy (2020) Vol. 19, Iss. 1, pp. 5-16
Open Access | Times Cited: 43
Showing 1-25 of 43 citing articles:
Low Vitamin D Status at Admission as a Risk Factor for Poor Survival in Hospitalized Patients With COVID-19: An Italian Retrospective Study
Marco Infante, Andrea Buoso, Massimo Pieri, et al.
Journal of the American Nutrition Association (2021) Vol. 41, Iss. 3, pp. 250-265
Open Access | Times Cited: 58
Marco Infante, Andrea Buoso, Massimo Pieri, et al.
Journal of the American Nutrition Association (2021) Vol. 41, Iss. 3, pp. 250-265
Open Access | Times Cited: 58
Novel coronavirus disease (COVID-19) pandemic: A recent mini review
Muhammad Fayyaz ur Rehman, Chaudhary Fariha, Aqsa Anwar, et al.
Computational and Structural Biotechnology Journal (2020) Vol. 19, pp. 612-623
Open Access | Times Cited: 46
Muhammad Fayyaz ur Rehman, Chaudhary Fariha, Aqsa Anwar, et al.
Computational and Structural Biotechnology Journal (2020) Vol. 19, pp. 612-623
Open Access | Times Cited: 46
Abnormal Liver Biochemistry Tests and Acute Liver Injury in COVID-19 Patients: Current Evidence and Potential Pathogenesis
Donovan McGrowder, Fabian Miller, Melisa Anderson Cross, et al.
Diseases (2021) Vol. 9, Iss. 3, pp. 50-50
Open Access | Times Cited: 32
Donovan McGrowder, Fabian Miller, Melisa Anderson Cross, et al.
Diseases (2021) Vol. 9, Iss. 3, pp. 50-50
Open Access | Times Cited: 32
A validated UHPLC-MS/MS method for simultaneous quantification of some repurposed COVID-19 drugs in rat plasma: Application to a pharmacokinetic study
Noha F. El Azab
Microchemical Journal (2022) Vol. 178, pp. 107321-107321
Open Access | Times Cited: 19
Noha F. El Azab
Microchemical Journal (2022) Vol. 178, pp. 107321-107321
Open Access | Times Cited: 19
SARS-CoV-2 and Systemic Lupus Erythematosus
Aikaterini Thanou, Amr H. Sawalha
Current Rheumatology Reports (2021) Vol. 23, Iss. 2
Open Access | Times Cited: 26
Aikaterini Thanou, Amr H. Sawalha
Current Rheumatology Reports (2021) Vol. 23, Iss. 2
Open Access | Times Cited: 26
The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19
Zelyn Lee, Craig R. Rayner, Jamie I. Forrest, et al.
American Journal of Tropical Medicine and Hygiene (2020) Vol. 104, Iss. 1, pp. 35-38
Open Access | Times Cited: 26
Zelyn Lee, Craig R. Rayner, Jamie I. Forrest, et al.
American Journal of Tropical Medicine and Hygiene (2020) Vol. 104, Iss. 1, pp. 35-38
Open Access | Times Cited: 26
What makes (hydroxy)chloroquine ineffective against COVID-19: insights from cell biology
Dania Altulea, Sjors Maassen, Maksim V. Baranov, et al.
Journal of Molecular Cell Biology (2021)
Open Access | Times Cited: 22
Dania Altulea, Sjors Maassen, Maksim V. Baranov, et al.
Journal of Molecular Cell Biology (2021)
Open Access | Times Cited: 22
Unravelling Insights into the Evolution and Management of SARS-CoV-2
Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonkululeko Avril Mbatha, et al.
BioMedInformatics (2024) Vol. 4, Iss. 1, pp. 385-409
Open Access | Times Cited: 2
Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonkululeko Avril Mbatha, et al.
BioMedInformatics (2024) Vol. 4, Iss. 1, pp. 385-409
Open Access | Times Cited: 2
In Silico Pharmacology and Drug Repurposing Approaches
Ghanshyam Parmar, Jay Mukesh Chudasama, Ashish Shah, et al.
(2023), pp. 253-281
Closed Access | Times Cited: 7
Ghanshyam Parmar, Jay Mukesh Chudasama, Ashish Shah, et al.
(2023), pp. 253-281
Closed Access | Times Cited: 7
Safety and efficacy of hydroxychloroquine as prophylactic against COVID-19 in healthcare workers: a meta-analysis of randomised clinical trials
Hwanhee Hong, Anne Friedland, Mengyi Hu, et al.
BMJ Open (2023) Vol. 13, Iss. 6, pp. e065305-e065305
Open Access | Times Cited: 7
Hwanhee Hong, Anne Friedland, Mengyi Hu, et al.
BMJ Open (2023) Vol. 13, Iss. 6, pp. e065305-e065305
Open Access | Times Cited: 7
Hydroxychloroquine Sulfate Related Hypoglycemia In A Non-Diabetic COVİD-19 Patient: A Case Report and Literature Review
Narimana Imanova Yaghji, Elif Kılıç Kan, Songul Akcan, et al.
Postgraduate Medicine (2021) Vol. 133, Iss. 5, pp. 548-551
Closed Access | Times Cited: 16
Narimana Imanova Yaghji, Elif Kılıç Kan, Songul Akcan, et al.
Postgraduate Medicine (2021) Vol. 133, Iss. 5, pp. 548-551
Closed Access | Times Cited: 16
Bioinformatics and systems biology analysis revealed PMID26394986-Compound-10 as potential repurposable drug against covid-19
Haseeb Nisar, Bilal Wajid, Faria Anwar, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 15, pp. 7972-7985
Open Access | Times Cited: 5
Haseeb Nisar, Bilal Wajid, Faria Anwar, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 15, pp. 7972-7985
Open Access | Times Cited: 5
Repurposed drug studies on the primary prevention of SARS-CoV-2 infection during the pandemic: systematic review and meta-analysis
Guiling Zhou, Stefan Verweij, Maarten J. Bijlsma, et al.
BMJ Open Respiratory Research (2023) Vol. 10, Iss. 1, pp. e001674-e001674
Open Access | Times Cited: 5
Guiling Zhou, Stefan Verweij, Maarten J. Bijlsma, et al.
BMJ Open Respiratory Research (2023) Vol. 10, Iss. 1, pp. e001674-e001674
Open Access | Times Cited: 5
Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents
Marco Infante, Nathalia Padilla, Rodolfo Alejandro, et al.
Medicina (2022) Vol. 58, Iss. 5, pp. 571-571
Open Access | Times Cited: 9
Marco Infante, Nathalia Padilla, Rodolfo Alejandro, et al.
Medicina (2022) Vol. 58, Iss. 5, pp. 571-571
Open Access | Times Cited: 9
A Comprehensive Assessment of Environmental Implications, Ecotoxicity and Bioaccumulation Potential of Repurposed Drug Hydroxychloroquine: From Challenges to Sustainability
Priyadarshini Gupta, Vibha Rani
Reviews of Environmental Contamination and Toxicology (2024) Vol. 262, Iss. 1
Closed Access | Times Cited: 1
Priyadarshini Gupta, Vibha Rani
Reviews of Environmental Contamination and Toxicology (2024) Vol. 262, Iss. 1
Closed Access | Times Cited: 1
28 Financing Emergency Research Response During Infectious Disease Outbreaks: Lessons from the World Bank and Other International Financial Institutions
Muhammad Ali Pate, Sulzhan Bali
Springer eBooks (2024), pp. 739-764
Closed Access | Times Cited: 1
Muhammad Ali Pate, Sulzhan Bali
Springer eBooks (2024), pp. 739-764
Closed Access | Times Cited: 1
THE DARK SIDE OF THE COVID-19 TREATMENTS ON MYCOBACTERIUM TUBERCULOSIS INFECTION
Flavio De Maio, Delia Mercedes Bianco, Giovanni Delogu
Mediterranean Journal of Hematology and Infectious Diseases (2022) Vol. 14, Iss. 1, pp. e2022021-e2022021
Open Access | Times Cited: 7
Flavio De Maio, Delia Mercedes Bianco, Giovanni Delogu
Mediterranean Journal of Hematology and Infectious Diseases (2022) Vol. 14, Iss. 1, pp. e2022021-e2022021
Open Access | Times Cited: 7
Journal of Vaccines & Vaccination
Debasis Datta, Samit Ghosal, Binayak Sinha, et al.
Journal of Vaccines & Vaccination (2018)
Open Access | Times Cited: 11
Debasis Datta, Samit Ghosal, Binayak Sinha, et al.
Journal of Vaccines & Vaccination (2018)
Open Access | Times Cited: 11
At-home coronavirus testing: the next game-changer?
Matthew W. McCarthy
Expert Review of Molecular Diagnostics (2021) Vol. 21, Iss. 1, pp. 1-2
Open Access | Times Cited: 10
Matthew W. McCarthy
Expert Review of Molecular Diagnostics (2021) Vol. 21, Iss. 1, pp. 1-2
Open Access | Times Cited: 10
Abnormal Liver Biochemistry Tests and Acute Liver Injury in COVID-19 Patients: Current Evidence and Potential Pathogenesis
Donovan McGrowder, Fabian Miller, Melisa Anderson Cross, et al.
(2021)
Open Access | Times Cited: 10
Donovan McGrowder, Fabian Miller, Melisa Anderson Cross, et al.
(2021)
Open Access | Times Cited: 10
Potential clinically significant drug‐drug interactions of hydroxychloroquine used in the treatment of COVID‐19
Mohitosh Biswas, Debendra Nath Roy
International Journal of Clinical Practice (2021) Vol. 75, Iss. 11
Open Access | Times Cited: 10
Mohitosh Biswas, Debendra Nath Roy
International Journal of Clinical Practice (2021) Vol. 75, Iss. 11
Open Access | Times Cited: 10
<p>Flattening the Risk: Pre-Exposure Prophylaxis for COVID-19</p>
Raphael B. Stricker, Melissa C. Fesler
Infection and Drug Resistance (2020) Vol. Volume 13, pp. 3689-3694
Open Access | Times Cited: 9
Raphael B. Stricker, Melissa C. Fesler
Infection and Drug Resistance (2020) Vol. Volume 13, pp. 3689-3694
Open Access | Times Cited: 9
Organoid technology and lung injury mouse models evaluating effects of hydroxychloroquine on lung epithelial regeneration
Fuxiaonan Zhao, Jianhai Wang, Qi Wang, et al.
EXPERIMENTAL ANIMALS (2022) Vol. 71, Iss. 3, pp. 316-328
Open Access | Times Cited: 6
Fuxiaonan Zhao, Jianhai Wang, Qi Wang, et al.
EXPERIMENTAL ANIMALS (2022) Vol. 71, Iss. 3, pp. 316-328
Open Access | Times Cited: 6
ZnO-chlorogenic acid nanostructured complex inhibits Covid-19 pathogenesis and increases hydroxychloroquine efficacy
Mosleh M. Abomughaid, Mohammed S. Nofal, Khaled Ismail Ghaleb, et al.
Journal of King Saud University - Science (2022) Vol. 34, Iss. 8, pp. 102296-102296
Open Access | Times Cited: 6
Mosleh M. Abomughaid, Mohammed S. Nofal, Khaled Ismail Ghaleb, et al.
Journal of King Saud University - Science (2022) Vol. 34, Iss. 8, pp. 102296-102296
Open Access | Times Cited: 6
Impact of prophylactic hydroxychloroquine on ultrastructural impairment and cellular SARS-CoV-2 infection in different cells of bronchoalveolar lavage fluids of COVID-19 patients
Shikha Chaudhary, Arti Joshi, Kishore Sesham, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Shikha Chaudhary, Arti Joshi, Kishore Sesham, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
